Loading...
YJ is not a good buy right now for an impatient investor. The stock is technically overbought (RSI_6 88.5) and sitting just below near-term resistance (R1 ~1.678), while fundamentals show sharp revenue contraction. With no Intellectia buy signals and no near-term catalysts, the risk/reward is unattractive at the current price (1.64).
Price/levels: Last close ~1.64. Key pivot ~1.472; resistance at R1 ~1.678 then R2 ~1.805; supports at S1 ~1.265 and S2 ~1.138. Trend/momentum: MACD histogram is positive (0.0435) and expanding, suggesting bullish momentum remains, but RSI_6 at ~88.5 signals extreme overbought conditions and elevated pullback risk. Moving averages: Converging MAs suggest the trend is not strongly established and could chop/revert. Pattern-based outlook: Similar-pattern stats imply a 60% chance of a small dip next day (-0.76%), with modest upside bias over 1 week (+1.24%) and 1 month (+3.28%). Net: upside exists but entry is poor given current overbought conditions near resistance.
Intellectia Proprietary Trading Signals:
Latest quarter: 2024/Q4. Growth trends: Revenue declined significantly (-34.88% YoY) to 97.12M, indicating contraction in the core business. Gross margin rose to 34.29% (+14.45% YoY), and net loss improved YoY (net income -85.05M, +29.14% YoY improvement), but EPS fell to -0.05 (-61.54% YoY). Overall: efficiency improved, but top-line weakness and worsening EPS make the fundamental setup weak for a momentum chase at current prices.
No analyst rating / price target change data was provided, so there is no clear Wall Street consensus signal to lean on. Pros based on available data: improving gross margin and narrower net loss. Cons: steep revenue decline and weaker EPS, which typically limit bullish institutional conviction.
